Categories
Cardiovascular
Diagnostics
Endocrinology
Health Insurance
Medical Devices
Mental Health
Nutrition
Oncology
Public Health
Sexual Health
Popular Articles
Cellulite Cream

How Genetics Influences Humans When Choosing A Mate
New light has been thrown on how humans choose their partners, a scientist told the annual conference of the European Society of Human Genetics on May 25. Professor Maria da GraÃýa Bicalho, head of the Immunogenetics and Histocompatibility Laboratory at the University of Parana, Brazil, says that her research had shown that people with diverse major histocompatibility complexes (MHCs) were more likely to choose each other as mates than those whose MHCs were similar, and that this was likely to be an evolutionary strategy to ensure healthy reproduction.
generic viagra online
Acute Stroke Centres Promise To 'revolutionise' Stroke Care Services
The growth of acute stroke care centres and systems of care could revolutionise clinicians" ability to treat patients with stroke, according to an analysis of services published ahead of print in the Journal of NeuroInterventional Surgery.
News of the day
Dramatic Drop In Deaths From Most Common Cancers
The death toll from three of the UK"s most common cancers has dropped to its lowest level for almost 40 years* - according to new figures released by Cancer Research UK.
Medical Devices

UT Gets Federal Stimulus Grant For Parkinson's Disease Research

The University of Texas Health Science Center at Houston has received a $412,500 federal stimulus grant for Parkinson"s disease research, the university announced today. It is the university"s first federal stimulus grant. Parkinson"s disease is an incurable brain disorder. Its symptoms include trembling, stiffness and problems with balance. An estimated one million Americans are diagnosed with the neurological disorder. The two-year grant will support efforts by researchers in the university"s Brown Foundation Institute of Molecular Medicine for the Prevention of Human Diseases (IMM) to develop a therapeutic vaccine. Rowen Chang, Ph.D, an IMM professor of protein chemistry, is the principal investigator on the grant that comes from The National Institute of Neurological Disorders and Stroke through the American Recovery and Reinvestment Act of 2009. Chuantao Jiang, M.D., Ph.D., an assistant research professor at the IMM, is co-principal investigator. Chang plans to add one or two researchers to the team of scientists in his lab with the funds. The grant extends through April 30, 2011. "We are excited about receiving this grant, which will support our research and help the economy by employing more scientists," Chang said. Chang believes he may be able to slow the progression of Parkinson"s disease and possibly even prevent it by targeting a protein associated with the disease called alpha-synuclein. If successful, Chang"s vaccine would work by strengthening the immune system"s ability to suppress the activity of alpha-synuclein through the production of antibodies. The effectiveness of this vaccine will be tested in transgenic mice expressing human alpha-synuclein. The American Recovery and Reinvestment Act was passed by Congress to jumpstart the economy and create jobs. "The focus of the research has been on creating "locked structures" of proteins by internal cross linking," said C. Thomas Caskey, M.D., IMM Director/CEO. "The application of this technology to creation of therapeutic antibodies for Parkinson"s disease is a creative approach to new therapies for a challenging disease." Chang has been on the faculty of the Institute of Molecular Medicine for about a decade and was one of the initial appointments. He obtained his master"s of science degree from the National Taiwan University in Taipei and his doctorate from the Australian National University at Canberra. Robert Cahill University of Texas Health Science Center at Houston


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

© Copyright 2009